WEST PHARMACEUTICAL SERVICES, INC. Accounts Payable
WEST PHARMACEUTICAL SERVICES, INC. (WST) had Accounts Payable of $252.70 million as of 2026-06-30, per its 10-Q filed 2026-07-23.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2026-07-23
- 2026-06-30: Accounts Payable, Current $252.70M.
- 2026-03-31: Accounts Payable, Current $252.30M.
- 2025-12-31: Accounts Payable, Current $253.70M.
- 2025-09-30: Accounts Payable, Current $255.80M.
| Period end | Accounts Payable, Current |
|---|---|
| 2026-06-30 | $252.70M 10-Q · filed 2026-07-23 |
| 2026-03-31 | $252.30M 10-Q · filed 2026-04-23 |
| 2025-12-31 | $253.70M 10-Q · filed 2026-07-23 |
| 2025-09-30 | $255.80M 10-Q · filed 2025-10-23 |
| 2025-06-30 | $239.00M 10-Q · filed 2025-07-24 |
| 2025-03-31 | $228.40M 10-Q · filed 2025-04-24 |
| 2024-12-31 | $239.30M 10-K · filed 2026-02-17 |
| 2024-09-30 | $224.30M 10-Q · filed 2024-10-24 |
| 2024-06-30 | $211.70M 10-Q · filed 2024-07-25 |
| 2024-03-31 | $240.10M 10-Q · filed 2024-04-25 |
| 2023-12-31 | $242.40M 10-K · filed 2025-02-18 |
| 2023-09-30 | $219.80M 10-Q · filed 2023-10-26 |
| 2023-06-30 | $218.00M 10-Q · filed 2023-07-27 |
| 2023-03-31 | $233.80M 10-Q · filed 2023-04-27 |
| 2022-12-31 | $215.40M 10-K · filed 2024-02-20 |
| 2022-09-30 | $188.90M 10-Q · filed 2022-10-27 |
| 2022-06-30 | $220.00M 10-Q · filed 2022-07-28 |
| 2022-03-31 | $248.20M 10-Q · filed 2022-04-28 |
| 2021-12-31 | $232.20M 10-K · filed 2023-02-21 |
| 2021-09-30 | $207.70M 10-Q · filed 2021-10-28 |
| 2021-06-30 | $205.10M 10-Q · filed 2021-07-30 |
| 2021-03-31 | $204.30M 10-Q · filed 2021-04-30 |
| 2020-12-31 | $213.10M 10-K · filed 2022-02-22 |
| 2020-09-30 | $180.30M 10-Q · filed 2020-10-23 |
| 2020-06-30 | $162.30M 10-Q · filed 2020-07-24 |
| 2020-03-31 | $157.90M 10-Q · filed 2020-04-24 |
| 2019-12-31 | $156.80M 10-K · filed 2021-02-23 |
| 2019-09-30 | $145.30M 10-Q · filed 2019-10-29 |
| 2019-06-30 | $152.10M 10-Q · filed 2019-07-29 |
| 2019-03-31 | $137.70M 10-Q · filed 2019-05-08 |
| 2018-12-31 | $130.40M 10-K · filed 2020-02-24 |
| 2018-09-30 | $125.20M 10-Q · filed 2018-10-30 |
| 2018-06-30 | $126.20M 10-Q · filed 2018-07-31 |
| 2018-03-31 | $127.60M 10-Q · filed 2018-05-08 |
| 2017-12-31 | $138.10M 10-K · filed 2019-02-28 |
| 2017-09-30 | $121.90M 10-Q · filed 2017-10-31 |
| 2017-06-30 | $130.90M 10-Q · filed 2017-08-01 |
| 2017-03-31 | $106.10M 10-Q · filed 2017-05-05 |
| 2016-12-31 | $122.00M 10-K · filed 2018-02-26 |
| 2016-09-30 | $99.00M 10-Q · filed 2016-10-31 |
| 2016-06-30 | $107.30M 10-Q · filed 2016-08-01 |
| 2016-03-31 | $97.50M 10-Q · filed 2016-05-06 |
| 2015-12-31 | $119.80M 10-K · filed 2017-02-28 |
| 2015-09-30 | $93.60M 10-Q · filed 2015-11-02 |
| 2015-06-30 | $91.40M 10-Q · filed 2015-08-03 |
| 2015-03-31 | $88.50M 10-Q · filed 2015-05-06 |
| 2014-12-31 | $103.10M 10-K · filed 2016-02-26 |
| 2014-09-30 | $91.40M 10-Q · filed 2014-11-03 |
| 2014-06-30 | $94.50M 10-Q · filed 2014-08-01 |
| 2014-03-31 | $98.40M 10-Q · filed 2014-05-08 |
| 2013-12-31 | $108.00M 10-K · filed 2015-02-25 |
| 2013-09-30 | $86.30M 10-Q · filed 2013-11-04 |
| 2013-06-30 | $88.40M 10-Q · filed 2013-08-05 |
| 2013-03-31 | $91.60M 10-Q · filed 2013-05-06 |
| 2012-12-31 | $102.90M 10-K · filed 2014-02-27 |
| 2012-09-30 | $81.30M 10-Q · filed 2012-11-05 |
| 2012-06-30 | $85.60M 10-Q · filed 2012-08-06 |
| 2012-03-31 | $82.70M 10-Q · filed 2012-05-04 |
| 2011-12-31 | $89.80M 10-K · filed 2013-02-27 |
| 2011-09-30 | $71.70M 10-Q · filed 2011-11-07 |
| 2011-06-30 | $73.40M 10-Q/A · filed 2011-08-08 |
| 2011-03-31 | $66.20M 10-Q · filed 2011-05-05 |
| 2010-12-31 | $63.20M 10-K/A · filed 2012-03-01 |
| 2010-09-30 | $56.30M 10-Q · filed 2010-11-05 |
| 2010-06-30 | $61.40M 10-Q · filed 2010-08-05 |
| 2009-12-31 | $68.40M 10-K · filed 2011-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |